- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 953974, 8 pages
The Associated Ion between the VDR Gene Polymorphisms and Susceptibility to Hepatocellular Carcinoma and the Clinicopathological Features in Subjects Infected with HBV
1Huzhou Central Hospital, Huzhou, Zhejiang 313000, China
2School of Life Sciences and Technology, Tongji University, Shanghai 200092, China
Received 18 November 2012; Revised 11 January 2013; Accepted 28 January 2013
Academic Editor: Tavan Janvilisri
Copyright © 2013 Xing Yao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- P. Małkowski, M. Pacholczyk, B. Łagiewska et al., “Hepatocellular carcinoma—epidemiology and treatment,” Przeglad Epidemiologiczny, vol. 60, no. 4, pp. 731–740, 2006.
- M. A. van den Bosch and L. Defreyne, “Hepatocellular carcinoma,” The Lancet, vol. 380, no. 9840, pp. 469–470, 2012.
- P. A. Farazi and R. A. DePinho, “The genetic and environmental basis of hepatocellular carcinoma,” Discovery Medicine, vol. 6, no. 35, pp. 182–186, 2006.
- R. Masuzaki, H. Yoshida, R. Tateishi, S. Shiina, and M. Omata, “Hepatocellular carcinoma in viral hepatitis: improving standard therapy,” Best Practice and Research: Clinical Gastroenterology, vol. 22, no. 6, pp. 1137–1151, 2008.
- A. K. Singal, “Silent cirrhosis in hepatitis B virus related hepatocellular carcinoma,” Hepato-Gastroenterology, vol. 55, no. 86-87, pp. 1734–1737, 2008.
- P. R. Wang, M. Xu, S. Toffanin, Y. Li, J. M. Llovet, and D. W. Russell, “Induction of hepatocellular carcinoma by in vivo gene targeting,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 28, pp. 11264–11269, 2012.
- N. F. Ma, S. H. Lau, L. Hu, S. S. Dong, and X. Y. Guan, “Hepatitis B virus X gene in the development of hepatocellular carcinoma,” Hong Kong Medical Journal, vol. 17, supplement 6, pp. 44–47, 2011.
- C. Cillo, G. Schiavo, M. Cantile et al., “The HOX gene network in hepatocellular carcinoma,” International Journal of Cancer, vol. 129, no. 11, pp. 2577–2587, 2011.
- Y. K. Yee, S. R. Chintalacharuvu, J. Lu, and S. Nagpal, “Vitamin D receptor modulators for inflammation and cancer,” Mini-Reviews in Medicinal Chemistry, vol. 5, no. 8, pp. 761–778, 2005.
- M. Guy, L. C. Lowe, D. Bretherton-Watt et al., “Vitamin D receptor gene polymorphisms and breast cancer risk,” Clinical Cancer Research, vol. 10, no. 16, pp. 5472–5481, 2004.
- M. L. Slattery, “Vitamin D receptor gene (VDR) associations with cancer,” Nutrition Reviews, vol. 65, no. 8, part 2, pp. S102–S104, 2007.
- N. Denzer, T. Vogt, and J. Reichrath, “Vitamin D receptor (VDR) polymorphisms and skin cancer: a systematic review,” Dermato-Endocrinology, vol. 3, no. 3, pp. 205–210, 2011.
- N. Buyru, A. Tezol, E. Yosunkaya-Fenerci, and N. Dalay, “Vitamin D receptor gene polymorphisms in breast cancer,” Experimental and Molecular Medicine, vol. 35, no. 6, pp. 550–555, 2003.
- D. G. Blazer III, D. M. Umbach, R. M. Bostick, and J. A. Taylor, “Vitamin D receptor polymorphisms and prostate cancer,” Molecular Carcinogenesis, vol. 27, no. 1, pp. 18–23, 2000.
- M. A. Murtaugh, C. Sweeney, K. N. Ma et al., “Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer,” Nutrition and Cancer, vol. 55, no. 1, pp. 35–43, 2006.
- W. Zhou, R. S. Heist, G. Liu et al., “Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 11, pp. 2239–2245, 2006.
- A. Kempinska-Podhorecka, E. Wunsch, T. Jarowicz et al., “Vitamin D receptor polymorphisms predispose to primary biliary cirrhosis and severity of the disease in polish population,” Gastroenterology Research and Practice, vol. 2012, Article ID 408723, 8 pages, 2012.
- A. Tanaka, S. Nezu, S. Uegaki et al., “Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations,” Journal of Hepatology, vol. 50, no. 6, pp. 1202–1209, 2009.
- A. Vogel, C. P. Strassburg, and M. P. Manns, “Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis,” Hepatology, vol. 35, no. 1, pp. 126–131, 2002.
- E. Falleti, D. Bitetto, C. Fabris et al., “Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis,” World Journal of Gastroenterology, vol. 16, no. 24, pp. 3016–3024, 2010.
- Y. J. Tan, “Hepatitis B virus infection and the risk of hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 17, no. 44, pp. 4853–4857, 2011.
- J. Hou, Z. Liu, and F. Gu, “Epidemiology and prevention of hepatitis B virus infection,” International Journal of Medical Sciences, vol. 2, no. 1, pp. 50–57, 2005.
- M. Moriyama, M. Mikuni, W. Longren et al., “Epidemiology of SEN virus infection among patients with hepatitis B and C in China,” Hepatology Research, vol. 27, no. 3, pp. 174–180, 2003.
- I. Merican, R. Guan, D. Amarapuka et al., “Chronic hepatitis B virus infection in Asian countries,” Journal of Gastroenterology and Hepatology, vol. 15, no. 12, pp. 1356–1361, 2000.
- Y. Jin, K. Abe, Y. Sato, K. Aita, H. Irie, and J. Shiga, “Hepatitis B and C virus infection and p53 mutations in human hepatocellular carcinoma in Harbin, Heilongjian Province, China,” Hepatology Research, vol. 24, no. 4, pp. 379–384, 2002.
- K. Migita, Y. Maeda, S. Abiru et al., “Polymorphisms of interleukin-1β in Japanese patients with hepatitis B virus infection,” Journal of Hepatology, vol. 46, no. 3, pp. 381–386, 2007.
- A. Al-Qahtani, M. Al-Ahdal, A. Abdo et al., “Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients,” Journal of Medical Virology, vol. 84, no. 9, pp. 1353–1359, 2012.
- J. H. Kim, S. J. Yu, B. L. Park et al., “TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence,” Digestive Diseases, vol. 29, no. 3, pp. 278–283, 2011.
- K. Y. Chan, C. M. Wong, J. S. Kwan et al., “Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection,” PLoS One, vol. 6, no. 12, Article ID e28798, 2011.
- C. Gross, A. V. Krishnan, P. J. Malloy, T. R. Eccleshall, X. Y. Zhao, and D. Feldman, “The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants,” Journal of Bone and Mineral Research, vol. 13, no. 11, pp. 1691–1699, 1998.
- G. K. Whitfield, L. S. Remus, P. W. Jurutka et al., “Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene,” Molecular and Cellular Endocrinology, vol. 177, no. 1-2, pp. 145–159, 2001.
- A. G. Uitterlinden, Y. Fang, J. B. J. van Meurs, H. A. P. Pols, and J. P. T. M. van Leeuwen, “Genetics and biology of vitamin D receptor polymorphisms,” Gene, vol. 338, no. 2, pp. 143–156, 2004.
- H. Arai, K. I. Miyamoto, Y. Taketani et al., “A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women,” Journal of Bone and Mineral Research, vol. 12, no. 6, pp. 915–921, 1997.
- L. Fan, X. Tu, Y. Zhu et al., “Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese,” Journal of Gastroenterology and Hepatology, vol. 20, no. 2, pp. 249–255, 2005.
- T. Hama, C. Norizoe, H. Suga et al., “Prognostic significance of vitamin D receptor polymorphisms in head and neck squamous cell carcinoma,” PLoS One, vol. 6, no. 12, Article ID e29634, 2011.